Radioligand Therapy for Neuroendocrine Tumors (NETs)

We are pleased to announce the release of RLT-Channel Episode 2, dedicated to radioligand therapy (RLT) in neuroendocrine tumors (NETs).

RLT-Channel is an educational video series designed to make radiotheranostics clearer and more accessible for patients, families, and healthcare professionals worldwide.

In this episode, you will learn:

  • What neuroendocrine tumors are

  • How radioligand therapy works

  • What patients can expect

  • Referral pathways and access considerations in Belgium and worldwide

Watch the video: 
Regarder la video:

To support viewers, we have also published a complementary NETs & RLT fact sheet, designed as a practical guide to help navigate both the episode and the therapy journey.

Download the Fact Sheet